Cargando…
Relevance of pathogenicity prediction tools in human RYR1 variants of unknown significance
Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle metabolism characterized by generalized muscle rigidity, increased body temperature, rhabdomyolysis, hyperkalemia and severe metabolic acidosis. The underlying mechanism of MH involves excessive Ca(2+) release from myotubes...
Autores principales: | Hoppe, Kerstin, Jurkat-Rott, Karin, Kranepuhl, Stefanie, Wearing, Scott, Heiderich, Sebastian, Merlak, Sonja, Klingler, Werner |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873245/ https://www.ncbi.nlm.nih.gov/pubmed/33564012 http://dx.doi.org/10.1038/s41598-021-82024-7 |
Ejemplares similares
-
Hypermetabolism in B–lymphocytes from malignant hyperthermia susceptible individuals
por: Hoppe, Kerstin, et al.
Publicado: (2016) -
Paxilline Prevents the Onset of Myotonic Stiffness in Pharmacologically Induced Myotonia: A Preclinical Investigation
por: Hoppe, Kerstin, et al.
Publicado: (2020) -
The role of fibrosis
in Duchenne muscular dystrophy
por: KLINGLER, WERNER, et al.
Publicado: (2012) -
Functional and genetic characterization of clinical malignant hyperthermia crises: a multi-centre study
por: Klingler, Werner, et al.
Publicado: (2014) -
Structural and Functional Changes in the Coupling of Fascial Tissue, Skeletal Muscle, and Nerves During Aging
por: Zullo, Alberto, et al.
Publicado: (2020)